DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Leonardi S, Mahaffey KW, White HD. et al.
Rationale and design of the Cangrelor versus standard therapy to acHieve optimal Management of Platelet InhibitiON PHOENIX trial.
Am Heart J 2012;
163: 768-776 e2.
We do not assume any responsibility for the contents of the web pages of other providers.